Skip to content

Study on the construction and effect evaluation of the whole-course nutrition management model for gastric cancer patients undergoing gastrectomy with the participation of clinical pharmacists

Study on the construction and effect evaluation of the whole-course nutrition management model for gastric cancer patients undergoing gastrectomy with the participation of clinical pharmacists

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087619
Enrollment
Unknown
Registered
2024-07-31
Start date
2019-08-24
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Clinical pharmacists whole-course Nutrition Management Group:Clinical pharmacists develop a program of nutritional support throughout the course
Non-clinical pharmacists intervention group:Nutritional support was carried out throughout the whole-course according to clinical routine

Sponsors

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18-80 years old who meet the diagnostic criteria for gastric cancer and need surgical intervention; 2.Preoperative radiotherapy and chemotherapy were not performed; 3.Voluntary subjects and signed informed consent; 4.Able to communicate well with researchers and follow the whole test requirements.

Exclusion criteria

Exclusion criteria: 1.Not meet the inclusion criteria; 2.Cachexia was assessed by nutrition; 3.Combined metabolic diseases: such as diabetes; 4.There are malignant tumors in other parts at the same time; 5.Patients with intraoperative metastases or who cannot undergo gastrectomy for gastric cancer according to the preoperative plan and turn to palliative care; 6.Patients with senile dementia, cerebral atrophy, acute stage or sequelae of cerebrovascular disease, and cognitive impairment; 7.Mental and neurological disorders that prevent medical cooperation; 8.Failure to effectively control local or systemic bacterial infection at acute stage; 9.The patient has surgical contraindications, such as serious cardiopulmonary disease and coagulation dysfunction; 10.Patients with shock and critical illness, unable to cooperate with operation and evaluation effect; 11.Enteral nutrition contraindications: patients with intestinal obstruction, gastrointestinal bleeding, severe shock, intestinal ischemia, etc.; 12.Other situations in which participation in the study was deemed inappropriate by the investigator.

Design outcomes

Primary

MeasureTime frame
Laboratory test indicators (prealbumin, albumin, total albumin, transferrin, vitamin B1, vitamin B12, folic acid, Vitamin D);Body composition analysis index(Muscle mass, body fat, skeletal muscle, intracellular water, extracellular water);Dietary standard rate;Percentage of weight loss;

Secondary

MeasureTime frame
Postoperative complications (e.g., diarrhea, bloating, gastroparesis, abdominal infection, ascites, gastrointestinal bleeding, intestinal obstruction);Postoperative recovery indicators (intestinal function recovery first exhaust, defecation time, fluid recovery time, total length of hospital stay);Economic evaluation index (hospitalization cost, total drug cost, nutrition preparation cost);

Countries

China

Contacts

Public ContactXiaojie Bian

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

18061678828@189.cn+86 180 6167 8828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026